Management of Metastatic Colorectal Cancer

  • Research type

    Research Study

  • Full title

    A Real World Evidence Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective

  • IRAS ID

    256380

  • Contact name

    Francisca Marti Marti

  • Contact email

    Kalena.Marti@christie.nhs.uk

  • Sponsor organisation

    Servier Affaires Médicales

  • Clinicaltrials.gov Identifier

    39997, NIHR CRN CPMS ID

  • Duration of Study in the UK

    3 years, 3 months, 31 days

  • Research summary

    This study aims to collect international, real-world information on treatment patterns for patients with metastatic colorectal cancer. There is currently limited data available on treatment patterns particularly for drugs which are used as third-line treatment after the disease has progressed on two previous types of treatment. The study will also collect information on the safety and effectiveness of treatments, the reasons for stopping some treatments and for choosing the next treatment, the use of healthcare resources and also the effect on the patient's quality of life.

  • REC name

    North West - Haydock Research Ethics Committee

  • REC reference

    19/NW/0455

  • Date of REC Opinion

    17 Jul 2019

  • REC opinion

    Favourable Opinion